PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1966 and is headquartered in Hwaseong-si, South Korea.
Research context
PharmGen Science Inc appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Wooridul Pharmaceutical Limited is currently in a long term uptrend where the price is trading 14.1% above its 200 day moving average.
From a valuation standpoint, the stock is 83.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Wooridul Pharmaceutical Limited's total revenue rose by 9.8% to $26B since the same quarter in the previous year.
Its net income has increased by 967.6% to $6B since the same quarter in the previous year.
Finally, its free cash flow grew by 87.5% to $-282M since the same quarter in the previous year.
Based on the above factors, Wooridul Pharmaceutical Limited gets an overall score of 5/5.